Trending...
- Allotex Announces New Investor and Expansion of Production Facilities USA - English USA - English
- "Street Fighter™ 6" Panel Announced for December 2nd at Los Angeles Comic Con; The Music of Street Fighter 6: A Special Look at the Video Game
- Lawmato relaunches its virtual consultation app with enhanced features
Eve Wellness located in SF offers the first FDA-approved ultrasound screening technology specifically designed for detecting cancer in dense breast tissue.
SAN FRANCISCO - BostonChron -- Eve Wellness, a San Francisco-based breast cancer screening clinic, is leading the charge in breast cancer screening by providing women the opportunity to get screened earlier, at any age, without a doctor referral, using their FDA-Approved GE ABUS ultrasound technology, powered by FDA-Approved AI (artificial intelligence), all without radiation. This comes on the heels of the FDA's new mandate, announced on March 9, 2023, requiring all mammography facilities to report breast density information and enhance communications with patients and providers.
The FDA's move is important because the risk of breast cancer is of real concern to many patients, said Dr. Harold Burstein, a medical oncologist at the Dana-Farber Cancer Institute in Boston and a professor at Harvard Medical School. "The identification of dense breast tissue can be a marker of slightly greater risk of getting breast cancer, and it may need additional breast imaging," said Burstein, who likened the challenge of reading mammograms to "looking through frosted glass."
More on Boston Chron
Breast density has been identified as a risk factor for breast cancer, and the FDA's new mandate aims to increase awareness and understanding of this risk. The mandate requires mammography facilities to provide patients with information about their breast density and the impact it can have on the accuracy of mammograms. Facilities are also required to communicate the findings with healthcare providers and provide recommendations for additional screening options, such as breast ultrasound.
"Today's action represents the agency's broader commitment to support innovation to prevent, detect and treat cancer," said Hilary Marston, M.D., M.P.H., FDA's Chief Medical Officer. "Since 1992, the FDA has worked to ensure patients have access to quality mammography. The impact of the Mammography Quality Standards Act on public health has been significant, including a steep decrease in the number of facilities that do not meet quality standards. This means that more women have access to consistent, quality mammography. We remain committed to advancing efforts to improve the health of women and strengthen the fight against breast cancer."
At Eve Wellness, breast ultrasound is the best option for women with dense breast tissue. Their GE ABUS ultrasound technology, powered by AI, can detect breast cancer at an earlier stage and without the use of radiation. With physician-read results back in less than 48 hours, Eve Wellness provides women with quick results, reducing anxiety and enabling early intervention.
More on Boston Chron
"Breast cancer claims the lives of nearly 43,000 women annually, and early detection is key to improving outcomes. Eve is on a mission to fill the void in breast cancer screening," said Brendan Foley, Co-Founder at Eve Wellness. "We are proud to lead the change in breast screening by providing women with access to the latest technology and empowering them to take control of their breast health."
Eve Wellness is committed to providing women with the best possible breast cancer screening options and is a game-changer in the fight against breast cancer. With the FDA's new mandate, women can feel more informed and empowered in their breast health decisions, and Eve Wellness is here to support them every step of the way.
For more information on Eve Wellness and their breast cancer screening services, visit their website at https://www.myevewellness.com/.
The FDA's move is important because the risk of breast cancer is of real concern to many patients, said Dr. Harold Burstein, a medical oncologist at the Dana-Farber Cancer Institute in Boston and a professor at Harvard Medical School. "The identification of dense breast tissue can be a marker of slightly greater risk of getting breast cancer, and it may need additional breast imaging," said Burstein, who likened the challenge of reading mammograms to "looking through frosted glass."
More on Boston Chron
- Steeped in Tradition: USAA Kicks Off 124th Army-Navy Game Celebrations in a Massive Way, Honoring 250th Anniversary of the Boston Tea Party
- Putnam Investments Announces 19(a) Notices for Closed-End Funds
- InventHelp Inventor Develops New Tool Belt for Cedar Shingles & Cedar Shingling Tools (BKC-128)
- Essential Speech and ABA Therapy to Expand Autism Services for a Growing Community
- Local Advocacy Organization, Keep Boston Goat Free, Celebrates Goat Ban in City of Boston
Breast density has been identified as a risk factor for breast cancer, and the FDA's new mandate aims to increase awareness and understanding of this risk. The mandate requires mammography facilities to provide patients with information about their breast density and the impact it can have on the accuracy of mammograms. Facilities are also required to communicate the findings with healthcare providers and provide recommendations for additional screening options, such as breast ultrasound.
"Today's action represents the agency's broader commitment to support innovation to prevent, detect and treat cancer," said Hilary Marston, M.D., M.P.H., FDA's Chief Medical Officer. "Since 1992, the FDA has worked to ensure patients have access to quality mammography. The impact of the Mammography Quality Standards Act on public health has been significant, including a steep decrease in the number of facilities that do not meet quality standards. This means that more women have access to consistent, quality mammography. We remain committed to advancing efforts to improve the health of women and strengthen the fight against breast cancer."
At Eve Wellness, breast ultrasound is the best option for women with dense breast tissue. Their GE ABUS ultrasound technology, powered by AI, can detect breast cancer at an earlier stage and without the use of radiation. With physician-read results back in less than 48 hours, Eve Wellness provides women with quick results, reducing anxiety and enabling early intervention.
More on Boston Chron
- Alnylam to Webcast Virtual R&D Day
- Global AI Training Dataset Market: A Comprehensive Analysis by BCC Research with a Projected CAGR of 25.4%
- SharkNinja Announces Pricing of Secondary Offering of Ordinary Shares
- Massachusetts: Governor Healey Installs Two Paintings by Artists of Color in Governor's Office
- Massachusetts: Healey-Driscoll Administration Holds First Regional Cabinet Meeting in Amherst
"Breast cancer claims the lives of nearly 43,000 women annually, and early detection is key to improving outcomes. Eve is on a mission to fill the void in breast cancer screening," said Brendan Foley, Co-Founder at Eve Wellness. "We are proud to lead the change in breast screening by providing women with access to the latest technology and empowering them to take control of their breast health."
Eve Wellness is committed to providing women with the best possible breast cancer screening options and is a game-changer in the fight against breast cancer. With the FDA's new mandate, women can feel more informed and empowered in their breast health decisions, and Eve Wellness is here to support them every step of the way.
For more information on Eve Wellness and their breast cancer screening services, visit their website at https://www.myevewellness.com/.
Source: Eve Wellness, Inc.
Filed Under: Health
0 Comments
Latest on Boston Chron
- Noble World Foundation Proposes UN Security Council Reform to Foster Global Peace
- Massachusetts: Governor Healey and Other Leaders of the Reproductive Freedom Alliance Urge Federal Government to Require Health Plan Coverage for All Contraception
- India Fest 2024 on Jan 27, 2024 at KY Expo Center
- Boston: Latest Updates from the Mayor's Office of Housing: December 1, 2023
- Massachusetts: Press Statement Governor Healey, Secretary Santiago Issue Statement on Passing of Staff Sgt. Jacob Galliher
- Genuine Hospitality, LLC Adds the Hampton Inn - Columbia, MO to Growing Portfolio
- Boston: Inaugural Community Health Equity Empowerment (CHEE) Fund Recipients Announced
- BofA Report Shows Fewer Prospective Homebuyers Willing to Wait for a Better Market Environment
- REA 'Peace of Mind on the Move' Study achieves Highly Commended recognition in the category Excellence in Coaching by ABP November 2023
- Revolutionizing FEC Chain Stores with Our Cutting-Edge Ordering& Warehousing System
- Boston: Barbados Celebrates 57 Years
- Boston: Honoring National Survivors of Homicide Awareness Month
- State Street to Further Consolidate Operating Model in India
- Media Personality Cyrus Webb celebrates 20 years and over 12,000 guests on Conversations LIVE radio show
- Revolutionizing Interaction: Surface Computing's $257.0 Billion Journey by 2028 - Insights from BCC Research
- Panovolo for macOS is now available
- Lumena, A New Luxury Oceanfront Condominium Takes Flight on Florida's Space Coast
- Dogs at the Dentist: How an unlikely partnership is helping treat dental anxiety
- Amundi US Declares Monthly Distributions for Pioneer Closed-End Funds
- SSV Network selects Randamu for Distributed Key Generation (DKG) Grant Award